"We are delighted that we were awarded this contract. We believe Hi-VNITM therapy could improve outcomes for our Veterans and active duty personnel and their families. We are honored to help ensure they receive the absolute best technology," said Joe Army, CEO of Vapotherm. "Being easy to do business with is a primary goal for Vapotherm and this contract makes it easier for these customers to buy product from us."
Currently, the contract includes both the Precision Flow Hi-VNITM system and the Vapotherm Transfer Unit which is used to help to ambulate and transfer patients while they are receiving therapy. Federal customers interested in learning more should contact your local representative as listed on www.vapotherm.com/representatives, or send us an email at firstname.lastname@example.org.
Vapotherm, Inc. is a privately held developer and manufacturer of advanced respiratory care technology based in Exeter, New Hampshire. The company develops innovative, comfortable, noninvasive technologies for respiratory support of patients with chronic or acute breathing disorders. Over 1,000,000 patients have been treated with Vapotherm Hi-VNITM Therapy. For more information, visit www.vapotherm.com.
Contact: Lise Halpern, VP Marketing & Clinicals (603) 658-0011
Back to News Article List...
Vapotherm Awarded Federal Supply Schedule Contract
November 15, 2016
EXETER, NH, November 15, 2016 – Vapotherm was awarded a Federal Supply Schedule (FSS) contract with the United States government, effective November 15, 2016. The contract simplifies the buying process for the 154 VA facilities, 14 Naval hospitals, and 33 Alaskan/Indian hospitals whose patients could benefit from Vapotherm High Velocity Nasal Insufflation (Hi-VNITM) technology.